The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned.

Authors :: Parekh M
Abrams D
Agerstrand C
Badulak J
Dzierba A
Alexander PMA
Price S
Fan E
Mullin D
Diaz R
Hodgson C
Brodie D
Source :: Clinics in chest medicine [Clin Chest Med] 2023 Jun; Vol. 44 (2), pp. 335-346. Date of Electronic Publication: 2022 Nov 29.
Publication Year :: 2023
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has seen an increase in global cases of severe acute respiratory distress syndrome (ARDS), with a concomitant increased demand for extracorporeal membrane oxygenation (ECMO). Outcomes of patients with severe ARDS due to COVID-19 infection receiving ECMO support are evolving. The need for surge capacity, practical and ethical limitations on implementing ECMO, and the prolonged duration of ECMO support in patients with COVID-19-related ARDS has revealed limitations in organization and resource utilization. Coordination of efforts at multiple levels, from research to implementation, resulted in numerous innovations in the delivery of ECMO.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)